Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Subgroup Analysis of the Phase Three Tolebrutinib HERCULES Trial: Disability Accumulation Outcomes in North American Participants

Author:Coyle, Patricia   Bar-Or, Amit   Reich, Daniel   Traboulsee, Anthony   Syed, Sana   Li, Ye   Vargas, Wendy   Fox, Robert   

Session Name:P9: Multiple Sclerosis: Clinical Trials 2  

Topic:Multiple Sclerosis  

Program Number:P9.003  

Author Institution:Stony Brook University Renaissance School of Medicine, Stony Brook, NY  University of Pennsylvania, Philadelphia, PA  Translational Neuroradiology Section, National Institutes of Health, Bethesda, MD  University of British Columbia, Vancouver, BC, Canada  Sanofi, Cambridge, MA  Sanofi, Bridgewater, NJ  Cleveland Clinic, Cleveland, OH  

Clinical Spectrum of SEZ6L2 Autoimmunity: A Case Report and Systematic Review

Author:Kobayashi, Goh   Hoshina, Yoji   Reda, Haatem   

Session Name:P9: Autoimmune Neurology: Central Nervous System 4  

Topic:Autoimmune Neurology  

Program Number:P9.003  

Author Institution:Eiju General Hospital, Tokyo, Japan  2. Massachusetts General Hospital, Cambridge, MA  Massachusetts General Hospital, Boston, MA  

Migraine Treatment and Diagnosis Optimization in a Family Medicine Residency Program

Author:Allison, Jessica   Baccari, Aubrey   Henriksen, Brian   Furman, David   

Session Name:P9: Headache: Care Delivery, Education, Advocacy, and Equity  

Topic:Headache  

Program Number:P9.003  

Author Institution:Fort Wayne Medical Education Program, FORT WAYNE, IN  

Progressive Multifocal Leukoencephalopathy in an Immunocompetent Host Treated with Pembrolizumab

Author:Upadhyay, Jitendra   Bararia, Akshit   Yadav, Deepak   Agarwal, Amit   SAHU, NAMAN   Pandey, Sanjay   

Session Name:P9: Infectious Disease: Opportunistic Infections 1  

Topic:Infectious Disease  

Program Number:P9.003  

Author Institution:Amrita Institute of Medical Sciences, Faridabad, Delhi National Capital Region, India  all india institute of medical sciences Bhopal, BHOPAL, India  

Sustained Clinical Efficacy and Long-term Safety of Intravenous Efgartigimod for Generalized Myasthenia Gravis: Part B of ADAPT NXT

Author:Seth, Arjun   Hussain, Yessar   Habib, Ali   Claeys, Kristl   Sahagian, Gregory   Cortés-Vicente, Elena   Guptill, Jeffery   Liu, Li   Jimenez, Rosa   Bougamra, Sirine   Masschaele, Delphine   Mantegazza, Renato   Meisel, Andreas   Attarian, Shahram   

Session Name:P9: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis Clinical Trials  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P9.003  

Author Institution:Northwestern University, IL  Austin Neuromuscular Center, TX  University of California, Irvine, CA  University Hopitals Leuven  and KU Leuven, Belgium  The Neurology Center of Southern California, CA  Hospital de la Santa Creu i Sant Pau  and Biomedical Research Institute Sant Pau , Spain  argenx, Belgium  Fondazione IRCCS Istituto Neurologico Carlo Besta, Italy  Charité – Universitätsmedizin Berlin, Germany  Reference Center for Neuromuscular Disorders and ALS Timone Hospital University, France